# Alexander McCampbell

> Alexander McCampbell is a startup investor at Apple Tree Partners (Cambridge). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Apple Tree Partners](https://shizune.co/investors/profile/apple-tree-partners)
- Location: Cambridge, United States
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/alexmccampbell/

Alexander McCampbell is a venture partner at ATP. A highly skilled pharmaceutical scientist specializing in rare and neurodegenerative diseases, Alex worked at Biogen for nine years, most recently as a vice president building and leading a translational team of 25 people in neuromuscular and muscle research. He has advanced eight agents into theclinic with a range of modalities, including antibodies, small molecules, and antisense oligonucleotides, in disease areas including amyotrophic lateral sclerosis, Alzheimer’s disease, and spinal muscular atrophy (SMA). These efforts have resulted to date in one approved drug for SMA (Spinraza™) and multiple drug candidates in proof of concept or pivotal stage trials. Alex has also been integral in multiple business development deals as the scientific point person on strategic collaborations. He has more than 30 publications spanning nearly two decades and multiple patents, and he has participated on scientific advisory boards and NIH study sections.Alex received his PhD in Neuroscience from the University of Pennsylvania and completed his post-doctoral training at Harvard Medical School.

## About Apple Tree Partners

VC Fund · New York, United States

ATP, a global leader in life sciences venture capital, is developing the next generation of transformative biotechnology companies. ATP creates science-based companies starting with assets at various stages: from working with scientists on pre-IP ideas, to spinouts from existing company pipelines. The firm provides flexible capital, strategicinsight, and operational resources to build sustainable, research-driven enterprises. ATP invests in its portfolio companies from seed stage through IPO and beyond and supports their management teams in strategic transactions and synergistic business combinations.

5 contacts available at Apple Tree Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Alexander McCampbell | Venture Partner | https://shizune.co/investors/profile/alexander-mccampbell |
| Andrew Bayliffe | Venture Partner | https://shizune.co/investors/profile/andrew-bayliffe |
| Anna Batarina | Partner | https://shizune.co/investors/profile/anna-batarina |
| Brian Vash | Entrepreneur in Residence | https://shizune.co/investors/profile/brian-vash |
| Daniel Finkelman | General Counsel | https://shizune.co/investors/profile/daniel-finkelman-9525 |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co